Although people are going to save money on average out-of-pocket costs, the benefit is not ideally structured to help people with chronic diseases. In general, the benefits are not going to be equally distributed. |
Blacks and Hispanics are going to save, but they will save less than whites both in absolute dollars and as a percent of their current out-of-pocket costs. |
Dually eligible people are going to have great savings but no one seems to talk about these other people. Do we need to expand subsidies to include these people who are still poor, and are still going to have trouble with medicines? |